These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23263825)
1. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147 [TBL] [Abstract][Full Text] [Related]
3. CD147, MMP9 expression and clinical significance of basal-like breast cancer. Liu Y; Xin T; Jiang QY; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C Med Oncol; 2013 Mar; 30(1):366. PubMed ID: 23292863 [TBL] [Abstract][Full Text] [Related]
4. CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer. Liu M; Tsang JYS; Lee M; Ni YB; Chan SK; Cheung SY; Hu J; Hu H; Tse GMK J Clin Pathol; 2018 Nov; 71(11):1007-1014. PubMed ID: 30099407 [TBL] [Abstract][Full Text] [Related]
5. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis]. Zhou S; Liu C; Wu SM; Wu RL Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819 [TBL] [Abstract][Full Text] [Related]
6. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Wu M; Wei W; Xiao X; Guo J; Xie X; Li L; Kong Y; Lv N; Jia W; Zhang Y; Xie X Med Oncol; 2012 Dec; 29(5):3240-9. PubMed ID: 22661383 [TBL] [Abstract][Full Text] [Related]
7. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. Xue YJ; Lu Q; Sun ZX Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007 [TBL] [Abstract][Full Text] [Related]
8. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer]. Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962 [TBL] [Abstract][Full Text] [Related]
9. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer. Chen M; Liu Z; Zheng K; Hu C; Peng P Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725 [TBL] [Abstract][Full Text] [Related]
10. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. Xu XY; Lin N; Li YM; Zhi C; Shen H Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236 [TBL] [Abstract][Full Text] [Related]
11. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648 [TBL] [Abstract][Full Text] [Related]
12. Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer. Zhang W; Liu H; Jiang J; Yang Y; Wang W; Jia Z Am J Transl Res; 2022; 14(5):2952-2961. PubMed ID: 35702119 [TBL] [Abstract][Full Text] [Related]
13. CD147 expression indicates unfavourable prognosis in prostate cancer. Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397 [TBL] [Abstract][Full Text] [Related]
14. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer. Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253 [TBL] [Abstract][Full Text] [Related]
15. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients. Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432 [TBL] [Abstract][Full Text] [Related]
16. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis. Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157 [TBL] [Abstract][Full Text] [Related]
17. Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry. Wu W; Wang R; Liu H; Peng J; Huang D; Li B; Ruan J Med Oncol; 2009; 26(2):117-23. PubMed ID: 18665467 [TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression. Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696 [TBL] [Abstract][Full Text] [Related]
19. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
20. Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors. Ramos EA; Silva CT; Manica GC; Pereira IT; Klassen LM; Ribeiro EM; Cavalli IJ; Braun-Prado K; Lima RS; Urban CA; Costa FF; Noronha L; Klassen G Rev Assoc Med Bras (1992); 2016 Nov; 62(8):774-781. PubMed ID: 27992019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]